4ANQ | Transferase | date | Mar 21, 2012 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Structure Of G1269a Mutant Anaplastic Lymphoma Kinase In Com Crizotinib | ||||||||||||||
authors | M.Mctigue, Y.Deng, W.Liu, A.Brooun | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Alk Tyrosine Kinase Receptor Chain: A Fragment: Kinase, Residues 1093-1411 Synonym: Anaplastic Lymphoma Kinase, Cd246 Ec: 2.7.10.1 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Spodoptera Frugiperda Expression_system_common: Fall Armyworm Expression_system_taxid: 7108 Expression_system_cell_line: Sf9 Expression_system_vector_type: Baculovirus Expression_system_plasmid: Pfastbac1 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.76 Å | ||||||||||||
ligand | VGH | enzyme | Transferase E.C.2.7.10.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | The design of potent and selective inhibitors to overcome clinical ALK mutations resistant to crizotinib., Huang Q, Johnson TW, Bailey S, Brooun A, Bunker KD, Burke BJ, Collins MR, Cook A, Cui JJ, Dack KN, Deal JG, Deng YL, Dinh DM, Engstrom LD, He M, Hoffman J, Hoffman RL, Shen H, Johnson P, Kania RS, Lam H, Lam JL, Le P, Li Q, Lingardo L, Liu W, West Lu M, McTigue MA, Palmer CL, Richardson PF, Sach NW, Smeal T, Smith GL, Stewart AE, Timofeevski SL, Tsaparikos K, Wang H, Zhu H, Zhu J, Zou HY, Edwards M, J Med Chem. 2014 Jan 16. PMID:24432909 |
Data retrieval |
View 4ANQ in 3D |
Visual 3D analysis of 4ANQ |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4ANQ |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |